Exagen Inc stock is traded at $4.13, with a volume of 3,356,988. It is down -6.35% in the last 24 hours and down -46.50% over the past month. Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Previous Close:
$4.41
Open:
$4.37
24h Volume:
3,356,988
Relative Volume:
3.08
Market Cap:
$105.37M
Revenue:
$68.38M
Net Income/Loss:
-$20.17M
P/E Ratio:
-
EPS:
-$0.8839
Net Cash Flow:
-$14.13M
1W Performance:
-41.83%
1M Performance:
-46.50%
6M Performance:
+13.46%
1Y Performance:
-54.16%
1-Day Range:
$3.85$4.38
1-Week Range:
$3.85$6.30
52-Week Range:
$2.59$9.74
Exagen Inc Stock (XGN) Company Profile
Name
Exagen IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
(760) 560-1501Address
1261 LIBERTY WAY, VISTA, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS